Drug intelligence / Profile preview

opium

Development stage
Phase 4
Modality
Small Molecules
Administration
Inhalation, Oral
01

Overview

Opium is a highly addictive non-synthetic narcotic drug obtained from the latex of the unripe seedpod of the poppy plant (Papaver somniferum)[2][4]. It is a complex mixture containing several alkaloids such as morphine (the principal active component), codeine, noscapine, thebaine, and papaverine[4][7]. Opium has been used for centuries for its analgesic (pain-relieving), hypnotic (sleep-inducing), antitussive (cough-suppressing), gastrointestinal and cognitive effects[1][8]. Its primary mechanism of action is agonism at opioid receptors—μ-opioid receptor (MOR), δ-opioid receptor (DOR), and κ-opioid receptor (KOR)—in the central and peripheral nervous systems. This leads to inhibition of neurotransmitter release by opening potassium channels and preventing voltage-gated calcium channel opening in neurons[6][7]. The result is reduced neuronal excitability and inhibition of pain signal transmission. Opium also causes euphoria followed by relaxation but can lead to physical dependence, tolerance, and overdose with symptoms such as respiratory depression or death[2][5][8]. While once widely used medicinally in forms like laudanum or paregoric for pain relief or diarrhea control, it has largely been replaced by purified alkaloids or synthetic opioids in modern medicine[8].

Other names
Ah-pen-yenAuntiAunti EmmaBig OBlack pillChandooChanduChinese MolassesChinese TobaccoDopiumDover's PowderDream GunDream StickFi-do-nieGeeGod's MedicineGondolaGoricGreat TobaccoGumaHop/hopsJoy PlantMidnight OilMiraOO.P.OpePeny anPingonPoxSkeeToxyToysWhe n-seeZeZero
02

Targets

DOR (Opioid Receptor Delta 1)KOR (Kappa opioid receptor)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on opium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on opium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call